# Mitral Valve Nonbacterial Thrombotic Endocarditis Associated With Antiphospholipid Syndrome in a Male Patient: A Comprehensive Case Report

**Authors:** Afshin Amirpour, Niloufar Razavi, Mahmoud Saeidi, Anahita Amirpour, Reyhaneh Zavar, Mohammadsadegh Sahebzade

PMC · DOI: 10.1155/carm/6425550 · Case Reports in Medicine · 2026-02-27

## TL;DR

A 34-year-old man with antiphospholipid syndrome developed mitral valve nonbacterial thrombotic endocarditis, diagnosed through surgery and confirmed by tissue analysis.

## Contribution

This case report provides a detailed clinical account of NBTE associated with APS in a male patient, emphasizing diagnostic challenges and management.

## Key findings

- The patient's mitral valve mass was confirmed as NBTE via histological analysis.
- Elevated anti–β2 glycoprotein I IgG levels supported a diagnosis of antiphospholipid syndrome.
- Warfarin therapy with monitored INR led to no complications after six months.

## Abstract

Nonbacterial thrombotic endocarditis (NBTE) is a rare cardiac disease with a nonspecific presentation associated with hypercoagulable states including malignancy and autoimmune disorders, such as antiphospholipid syndrome (APS) and systematic lupus erythematosus. A 34‐year‐old male with a history of pulmonary thromboembolism presented to the hospital complaining of chest pain as an initial symptom. Transthoracic echocardiography revealed the presence of a mass‐like lesion adhering to the anterior leaflet of the mitral valve. Once infective endocarditis was excluded, further imaging studies suggested that the cardiac neoplasm was the primary cause of the patient’s symptoms, and the patient underwent surgical excision of mass along with mitral valve replacement. Microscopic analysis of the removed mitral valve mass indicated the presence of fibrotic tissue with thick collagen bundles and no inflammatory infiltrates, supporting the diagnosis of NBTE. Investigations for underlying conditions demonstrated persistent elevated titers of anti–β2 glycoprotein I IgG, supporting a diagnosis of APS. The patient was started on warfarin therapy with a closely monitored International Normalized Ratio (INR). After 6 months of follow‐up, the patient reported no complications. This case highlights the importance of considering NBTE as a potential differential diagnosis in patients with intracardiac mass and inspecting associated conditions such as APS, as well as challenges encountered in diagnosis and management.

## Linked entities

- **Chemicals:** warfarin (PubChem CID 54678486)
- **Diseases:** Nonbacterial thrombotic endocarditis (MONDO:0000610), Antiphospholipid syndrome (MONDO:0017278)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, LCT (lactase) [NCBI Gene 3938] {aka LAC, LPH, LPH1}, F5 (coagulation factor V) [NCBI Gene 2153] {aka FVL, PCCF, RPRGL1, THPH2, fV}, APOH (apolipoprotein H) [NCBI Gene 350] {aka B2G1, B2GP1, BG}
- **Diseases:** Cardiac neoplasms (MESH:D006338), intracardiac mass (MESH:C538262), fibroelastoma (MESH:D000084122), Primary tumors (MESH:D001932), oral and genital aphthae (MESH:D013281), heart failure (MESH:D006333), Endocarditis (MESH:D004696), depression (MESH:D003866), tricuspid valve regurgitation (MESH:D014262), embolic events (MESH:D004617), Raynaud's phenomenon (MESH:D011928), coronary artery disease (MESH:D003324), cardiac condition (MESH:D006331), thromboembolic (MESH:D013923), bacteremia (MESH:D016470), thrombocytopenia (MESH:D013921), myocardial infarction (MESH:D009203), coagulation disorders (MESH:D001778), infective (MESH:D007239), dizziness (MESH:D004244), arterial, venous, and microvascular thrombosis (MESH:D020246), Antiphospholipid Syndrome (MESH:D016736), arthralgia (MESH:D018771), rheumatoid factor (MESH:D001171), weight loss (MESH:D015431), rheumatoid arthritis (MESH:D001172), Thrombotic (MESH:D013927), RF (MESH:C538347), lupus anticoagulant (MESH:C531622), arthritis (MESH:D001168), placental insufficiency (MESH:D010927), hypokinesia (MESH:D018476), NBTE (MESH:D059905), hematologic disorders (MESH:D006402), hematological and solid malignancies (MESH:D019337), fever (MESH:D005334), PE (MESH:D011655), vomiting (MESH:D014839), hypoxia (MESH:D000860), paraneoplastic syndromes of malignancy (MESH:D010257), MVR (MESH:D008944), masses (MESH:C536030), Libman-Sacks endocarditis (MESH:D008180), nausea (MESH:D009325), autoimmune condition (MESH:D001327), hemorrhagic (MESH:D006470), skin rashes (MESH:D005076), pleural effusion (MESH:D010996), cardiac myxomas (MESH:D009232), hypercoagulable (MESH:D019851), chest pain (MESH:D002637), cardiac valve (MESH:D006349), cancer (MESH:D009369), Sjogren's-syndrome-related antigen A (MESH:D012859), dyspnea (MESH:D004417), embolic stroke (MESH:D000083262), platelet aggregation (MESH:D001791), syncope (MESH:D013575), inflammatory (MESH:D007249), lipomas (MESH:D008067)
- **Chemicals:** warfarin (MESH:D014859), creatinine (MESH:D003404), rivaroxaban (MESH:D000069552), ampicillin-sulbactam (MESH:C035444), Cr (MESH:D002857), rituximab (MESH:D000069283), nitroglycerin (MESH:D005996), 2-mercapto ethanol (MESH:D008623), DOACs (-), hydroxychloroquine (MESH:D006886), vancomycin (MESH:D014640), vitamin D (MESH:D014807)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949334/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949334/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949334/full.md

---
Source: https://tomesphere.com/paper/PMC12949334